Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis
Open Access
- 5 September 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 29 (11), 2092-2099
- https://doi.org/10.1093/ndt/gft280
Abstract
Phosphate binders (PBs) account for about one half of the daily pill burden for US hemodialysis (HD) patients, which may reduce adherence. Adherence can be estimated by the medication possession ratio (MPR), which is defined as the proportion of time a patient had sufficient medication to have taken it as prescribed. Gaps of time between prescription fills lower the patient's MPR. We assessed the association of PB pill burden and adherence (MPR) with phosphorus goal attainment. Using pharmacy management program data, HD patients on PB monotherapy were tracked from first PB fill during 1 January 2007–30 June 2011 for 1 year, or until PB change or censoring. Data were assessed with generalized linear models. We analyzed 8616 patients. Higher pill burden was associated with lower adherence. Lower adherence tended to be associated with higher mean phosphorus levels and lower percentage of patients with serum phosphorus ≤5.5 mg/dL (P < 0.001). The association between adherence and these clinical outcomes was most pronounced in the lowest and highest pill burden strata (3–6, >12–15, >15). Adherence, as measured by the MPR, was negatively related to higher pill burden and phosphorus levels and positively related to patients in the phosphorus target range. Within pill burden strata, phosphorus increased and patients in the target range generally decreased with decreasing adherence, suggesting that patients prescribed fewer PB pills are less likely to have treatment gaps, and may be more likely to achieve phosphorus targets.This publication has 27 references indexed in Scilit:
- Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis PatientsClinical Journal of the American Society of Nephrology, 2009
- Phosphorus Binders and Survival on HemodialysisJournal of the American Society of Nephrology, 2009
- Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)American Journal of Kidney Diseases, 2008
- Higher Strength Lanthanum Carbonate Provides Serum Phosphorus Control With a Low Tablet Burden and Is Preferred by Patients and PhysiciansClinical Journal of the American Society of Nephrology, 2008
- A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal diseaseBMC Nephrology, 2008
- Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patientsKidney International, 2006
- Improving Outcomes for Dialysis Patients in the International Dialysis Outcomes and Practice Patterns StudyClinical Journal of the American Society of Nephrology, 2006
- Relationship of Phosphorus and Calcium-Phosphorus Product With Mortality in CKDAmerican Journal of Kidney Diseases, 2005
- Nonadherence in hemodialysis: Associations with mortality, hospitalization, and practice patterns in the DOPPSKidney International, 2003
- Factors Associated with Adherence to the Dietary Protein Intervention in the Modification of Diet in Renal Disease StudyJournal of the American Dietetic Association, 1995